In September 2025, the U.S. Food and Drug Administration (FDA) approved several new cancer therapies and supportive care ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...

Original Medicare (Part A and Part B), Part D, and Medicare Advantage typically offer coverage for the osteoporosis drug Prolia. However, individuals must meet certain requirements for Part B coverage ...

More men are now living long enough to develop osteoporosis. But few are aware of the risk, and fewer still are screened and ...

Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for ...

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...

Hyderabad: Dr Reddy's Laboratories Ltd., has announced that the European Medicines Agency's (EMA) Committee for Medicinal ...

Question: My doctor recommended vaccines for this fall, how are they covered by Original Medicare? Answer: Vaccines and injections prescribed by our physicians are covered differently depending on ...

The FDA has approved Bosaya and Aukelso, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.

Dr Reddy’s receives positive CHMP opinion from EMA for AVT03, a proposed biosimilar of Prolia and Xgeva: Our Bureau, Bengaluru Tuesday, September 23, 2025, 13:30 Hrs [IST] Dr Re ...